Deficiency of melanocortin 5 receptor exacerbates proteinuria and podocytopathy after glomerular injury

Deficiency of melanocortin 5 receptor exacerbates proteinuria and podocytopathy after glomerular injury

Bibliographic Details
Main Authors:	Bohan Chen, Yan Ge, Lance Dworkin, Rujun Gong
Format:	Article
Language:	English
Published:	The University of Toledo 2023-12-01
Series:	Translation
Subjects:	nephrotoxic serum (NTS)-elicited podocytopathy MC5R proteinuric glomerulopathies Nephrology Research
Online Access:	https://openjournals.utoledo.edu/index.php/translation/article/view/842

Similar Items

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats With Puromycin Aminonucleoside Nephrosis
by: Bohan Chen, et al.
Published: (2022-06-01)

Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases
by: Rajib K. Gupta, et al.
Published: (2020-08-01)

Pharmacological Melanocortin 5 Receptor Activation Attenuates Glomerular Injury and Proteinuria in Rats with Puromycin Aminonucleoside Nephrosis
by: Bohan Chen
Published: (2023-05-01)

Gangliosides in Podocyte Biology and Disease
by: Berkan Savas, et al.
Published: (2020-12-01)

Cytoskeleton Rearrangement in Podocytopathies: An Update
by: Sijia Ma, et al.
Published: (2024-01-01)

Delayed Onset Minimal Change Disease as a Manifestation of Lupus Podocytopathy
by: Rasha Aly, et al.
Published: (2021-10-01)

The Role of Parietal Epithelial Cells in the Pathogenesis of Podocytopathy
by: Zhi-hang Li, et al.
Published: (2022-03-01)

Age-related GSK3β overexpression drives podocyte senescence and glomerular aging
by: Yudong Fang, et al.
Published: (2022-02-01)

The redox-sensitive GSK3β is a key regulator of glomerular podocyte injury in type 2 diabetic kidney disease
by: Mengxuan Chen, et al.
Published: (2024-06-01)

Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review
by: Xiao-juan Yu, et al.
Published: (2018-11-01)

Drug-Induced Podocytopathies: Report of Four Cases and Review of the Literature
by: Diamanto Athanasopoulou, et al.
Published: (2023-05-01)

Mitochondrial Oxidative Stress and Cell Death in Podocytopathies
by: Yu-Ting Zhu, et al.
Published: (2022-03-01)

Pathogenic Role of MicroRNA Dysregulation in Podocytopathies
by: Feng Liu, et al.
Published: (2022-06-01)

Combined crystal-storing histiocytosis, light chain proximal tubulopathy, and light chain crystalline podocytopathy in a patient with multiple myeloma: a case report and literature review
by: Li Zhu, et al.
Published: (2023-12-01)

JAK inhibitor blocks COVID-19 cytokine–induced JAK/STAT/APOL1 signaling in glomerular cells and podocytopathy in human kidney organoids
by: Sarah E. Nystrom, et al.
Published: (2022-06-01)

Mycophenolate mofetil and telmisartan for the treatment of proteinuria secondary to minimal change disease podocytopathy in a dog
by: Victoria Travail, et al.
Published: (2022-11-01)

Podocytopathy Associated with IgA Nephropathy in Pregnancy: A Challenging Association
by: Alejandra Orozco Guillén, et al.
Published: (2023-02-01)

Study of urinary markers of different podocytopathies by proteomic analysis
by: Anatoliy A. Vinogradov, et al.
Published: (2023-08-01)

Hyperinsulinemic milieu elicits glomerular podocyte impairment and dysfunction via inducing GSK3beta hyperactivity
by: Mengxuan Chen, et al.
Published: (2023-12-01)

GSK3beta: a key regulator of glomerular podocyte injury in diabetic kidney disease
by: Mengxuan Chen, et al.
Published: (2023-12-01)

Dock5 Deficiency Promotes Proteinuric Kidney Diseases via Modulating Podocyte Lipid Metabolism
by: Hua Qu, et al.
Published: (2024-03-01)

Anticancer Drug-Induced Acute Kidney Injury
by: Hassan Izzedine, et al.
Published: (2017-07-01)

Lupus podocytopathy and antiphospholipid syndrome in a child with SLE: A case report and literature review
by: Guo-min Li, et al.
Published: (2022-08-01)

Role of Protein Kinase C (PKC) in Podocytes and Development of Glomerular Damage in Diabetic Nephropathy
by: Beina eTeng, et al.
Published: (2014-11-01)

Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation
by: Sagar Bhayana, et al.
Published: (2024-01-01)

Histone Deacetylases Take Center Stage on Regulation of Podocyte Function
by: Min Liu, et al.
Published: (2020-04-01)

TYRO3 agonist as therapy for glomerular disease
by: Fang Zhong, et al.
Published: (2023-01-01)

Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Hereditary Podocytopathies, Alport Syndrome, and FSGS: A Case Series to Better Plan a Large-Scale Study
by: Jan Boeckhaus, et al.
Published: (2021-07-01)

Glomerular Endothelial Cell-Derived miR-200c Impairs Glomerular Homeostasis by Targeting Podocyte VEGF-A
by: Raluca Ursu, et al.
Published: (2022-12-01)

Fibronectin Glomerulopathy: A Rare Autosomal Dominant Glomerular Disease
by: Jing Wu, et al.
Published: (2017-01-01)

Twist1 in podocytes ameliorates podocyte injury and proteinuria by limiting CCL2-dependent macrophage infiltration
by: Jiafa Ren, et al.
Published: (2021-08-01)

suPAR, a Circulating Kidney Disease Factor
by: Changli Wei, et al.
Published: (2021-10-01)

The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease
by: Yu Sun, et al.
Published: (2021-09-01)

Crystalline podocytopathy and tubulopathy without overt glomerular proteinuria in a patient with multiple myeloma
by: Eun Jeong Lee, et al.
Published: (2016-12-01)

MC1R Deficiency Enhances Th1 Response and Impairs Regulatory T Cell Homeostasis In Nephrotoxic Serum Nephritis
by: Bohan Chen
Published: (2023-05-01)

Essential role and therapeutic targeting of the glomerular endothelial glycocalyx in lupus nephritis
by: Hiroyuki Kadoya, et al.
Published: (2020-10-01)

Proteinuria, Estimated Glomerular Filtration Rate and Urinary Retinol-Binding Protein as Clinical Predictors of Long-Term Allograft Outcomes in Transplant Glomerulopathy
by: Xue Li, et al.
Published: (2018-12-01)

Does treating with anti–PD-1 to improve glomerular health come without a cost?
by: Kenar D. Jhaveri, et al.
Published: (2022-11-01)

GDF-15 Suppresses Puromycin Aminonucleoside-Induced Podocyte Injury by Reducing Endoplasmic Reticulum Stress and Glomerular Inflammation
by: Ekaterina von Rauchhaupt, et al.
Published: (2024-04-01)

Intravital imaging reveals glomerular capillary distension and endothelial and immune cell activation early in Alport syndrome
by: Georgina Gyarmati, et al.
Published: (2022-01-01)